The purpose of this study was to describe a novel heterozygous missense variant in the nuclear receptor subfamily 3 group C member 1 ligand-binding domain causing primary generalized glucocorticoid resistance and highlight diagnostic pitfalls that can mimic Cushing’s disease.
Clinical caseA 22-year-old woman was evaluated for suspected Cushing’s disease after elevated cortisol levels and pituitary imaging findings. She underwent three transsphenoidal surgeries, but hypercortisolism and clinical symptoms including hirsutism, acne, menstrual irregularities, and weight gain persisted. The absence of classical Cushing’s stigmata prompted genetic evaluation, which led to the diagnosis of primary generalized glucocorticoid resistance.
MethodsWhole-exome sequencing was performed in the index case. The identified variant was validated by Sanger sequencing and segregation analysis was carried out in her sister.
ResultsA novel heterozygous, likely pathogenic missense variant (NM_000176.3:c.1940T>C, p.(Leu647Pro)) in the nuclear receptor subfamily 3 group C member 1 gene was detected in two siblings.
ConclusionsWe describe a novel nuclear receptor subfamily 3 group C member 1 variant associated with primary generalized glucocorticoid resistance, expanding the mutational spectrum of glucocorticoid receptor defects. This case underscores the importance of considering primary generalized glucocorticoid resistance in patients with adrenocorticotropic hormone-dependent hypercortisolism lacking typical Cushing’s features to prevent unnecessary invasive procedures and guide appropriate genetic counseling
Keywords NR3C1 - ADRENAL - glucocorticoid receptor - glucocorticoid resistance syndrome Publication HistoryReceived: 19 March 2026
Accepted: 02 April 2026
Article published online:
16 April 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Comments (0)